Oesophageal Adenocarcinoma
15 clinical trials · Condition
◉ Watch Oesophageal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Combination of Capmatinib + Spartalizumab in Advanced Oesogastric Adenocarcinoma (NCT05135845) | Assistance Publique - Hôpitaux de Paris | 2022-03-22 |
| Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy (NCT04554771) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-01-27 |
| M6620 Plus Standard Treatment in Oesophageal and Other Cancer (NCT03641547) | University of Oxford | 2018-12-04 |
| Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer (NCT03399071) | Royal Marsden NHS Foundation Trust | 2017-07-31 |
| Prehabilitation of Patients With oEsophageal Malignancy Undergoing Peri-operative Treatment (NCT03626610) | Guy's and St Thomas' NHS Foundation Trust | 2016-11-01 |
| Effects of Chemotherapy on Muscle Mass and Exercise Performance in Patients With Oesophageal Cancer. (NCT01742312) | University of Nottingham | 2011-10-01 |
Track Oesophageal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.